Humedica Inc., a new health care data analytics vendor, has officially launched, backed by $30 million in capital from four investment firms.
The Boston-based company's remotely hosted applications offer analytics, reporting and benchmarking functions. The applications are designed to pull clinical data across an enterprise to analyze clinical and operational performance; identify and compare best practices; identify high-cost and high-risk patients in real-time to reduce preventable complications; and benchmark performance, according to the Boston-based vendor. Applications also are available for the life sciences industry.
Leaders of Humedica have backgrounds in pharmaceutical informatics, clinical trials, privacy issues, data extraction and electronic data interchange. Many most recently served at investment firm Leerink Swann, which is an investor in the new company. Other investors include Bain Capital Ventures, General Catalyst Partners and North Bridge Venture Partners.
This article can also be found at HealthDataManagement.com.